Marvell Lumentum Deal Can Stretch to August 2028, Filing Shows
Marvell Technology has agreed to buy Lumentum in an all-stock deal valued at $115 billion including debt. Lumentum shareholders would receive 4.500 Marvell shares each, worth about $1,132 a share when the United States companies announced the deal on 2 November 2026. The Marvell Lumentum deal can close as late as August 2028 under the agreement.
What Marvell Agreed to Pay for Lumentum
Marvell Technology, the Nasdaq-listed United States semiconductor company that designs data-centre networking and storage chips, is acquiring Lumentum Holdings, the United States maker of lasers and optical components used to move data inside artificial-intelligence data centres. Both companies are listed on Nasdaq, and the transaction is governed by United States law.
The consideration is entirely in Marvell shares. There is no cash component. Each Lumentum share converts into 4.500 shares of Marvell common stock, a figure the companies describe as a fixed exchange ratio, meaning the number of shares is set now and does not adjust if either share price moves.
| Term | Figure as announced on 2 November 2026 |
|---|---|
| Exchange ratio | 4.500 Marvell shares per Lumentum share, fixed |
| Implied value per Lumentum share | About $1,132 |
| Premium | About 23.9% over Lumentum’s 28 October 2026 close |
| Implied enterprise value | $115 billion, including debt |
| Equity value | $102.5 billion, as reported by Reuters |
| Ownership of combined company | About 67% Marvell holders, about 33% Lumentum holders |
| Expected close | First half of calendar 2028 |
The premium is measured against 28 October 2026, which the companies’ joint announcement calls the last trading day before market speculation about a deal began. Bloomberg reported the talks after that session closed.
Marvell said it has line of sight to more than $1 billion in annual run-rate cost savings, mostly in cost of goods sold, and expects the deal to add to its non-GAAP earnings per share in the first year after closing. It puts the combined addressable market at about $550 billion by 2030, against $400 billion for Marvell alone and more than $90 billion for Lumentum.
Why $1,132 a Share Is Not a Dollar Promise
The $1,132 figure is an arithmetic result, not a price Marvell has committed to pay. Because the ratio is fixed at 4.500 shares and no cash changes hands, the dollars a Lumentum holder eventually receives depend entirely on what Marvell stock is worth on the day the deal closes.
That $1,132 corresponds to a Marvell share price of about $252, which is roughly where the stock sat before news of the talks emerged. Marvell shares fell 13.24% on 29 October 2026, the session after Bloomberg’s report, and fell again on announcement day.
On Monday 2 November 2026, Marvell was down more than 10% and Lumentum down more than 15%, Reuters reported during the session. Earlier the same morning, at 8:53 a.m. Eastern Time, 24/7 Wall St. quoted Marvell at $190.43 and Lumentum at $788.51. At a Marvell price of about $190, the fixed ratio implies roughly $857 per Lumentum share rather than $1,132.
Lumentum trading well below the announced implied value is the ordinary pattern for a deal that is a long way from completion, and it reflects both the share-price link and the time still to run. All of these readings are intraday: United States markets had not closed when this article was written, and every figure in this section will have moved by the next session.
The Deadline in the Merger Agreement Runs to 2028
The companies guide publicly to a close in the first half of calendar 2028. The merger agreement itself, signed on 1 November 2026, sets a shorter initial deadline and then allows it to be pushed back three times.
According to Lumentum’s Form 8-K, the outside date is “11:59 p.m. Pacific Time on November 1, 2027,” extendable in stages if the required regulatory approvals have not been obtained:
- 1 November 2027: The initial outside date, one year after signing.
- 1 February 2028: First extension, available if regulatory approvals are still outstanding.
- 1 May 2028: Second extension on the same basis.
- 1 August 2028: Third and final extension, the latest date the agreement contemplates.
The gap between those two timelines is worth noting. A close in the first half of calendar 2028 is already past the initial deadline and past the first extension, which means the companies’ own public guidance assumes at least two extensions will be needed. Neither company has said which regulatory reviews it expects to take that long.
Eighteen months or more is unusually long for an all-stock transaction between two listed companies. It is not, by itself, evidence of a problem: large semiconductor deals routinely require clearances in several jurisdictions, and Lumentum’s own earlier purchases of Oclaro in 2018 and NeoPhotonics in 2022 both waited on approval from China’s State Administration for Market Regulation, the Chinese competition regulator.
Three Break Fees, and What Each One Covers
The merger agreement sets three separate termination fees. The amounts in Lumentum’s filing match those reported by Reuters.
| Fee | Amount | Who pays, and when |
|---|---|---|
| Marvell termination fee | $5.8 billion | Marvell, if its board withdraws its recommendation, or if Marvell terminates to accept a superior proposal for itself |
| Lumentum termination fee | $2.9 billion | Lumentum, in corresponding circumstances |
| Regulatory termination fee | $3.2 billion | Marvell, if the deal fails on antitrust or foreign-investment grounds, or is not completed by the outside date |
The $3.2 billion regulatory fee is the figure that quantifies the timetable risk. A reverse termination fee of this kind is the acquirer’s agreed payment to the target if competition or national-security review defeats the transaction, and its size is a rough measure of how much regulatory risk the parties priced in. It becomes payable only where the other closing conditions have been satisfied or could have been, so it covers failure caused by regulators rather than by either company changing its mind.
Fees of this shape are becoming a standard feature of large technology transactions. The Salesforce acquisition of Braze, announced in October 2026, carried a $300 million regulatory break fee on a far smaller deal, and the Schneider Electric purchase of PTC was structured around its own financing and approval conditions.
What Has to Happen Before the Deal Can Close
Nothing about this transaction is settled yet. The filing lists the conditions that must be met first:
- Lumentum shareholder vote: Lumentum stockholders must adopt the merger agreement.
- Marvell shareholder vote: Marvell stockholders must approve both the share issuance and an amendment to Marvell’s charter.
- United States antitrust clearance: The waiting period under the Hart-Scott-Rodino Act, the United States pre-merger notification law, must expire or be terminated.
- Other regulatory approvals: Certain other required clearances, including under foreign investment laws, must be obtained.
- No legal restraint: No court or regulator may have blocked the deal.
- Registration statement: Marvell’s Form S-4, which will contain the joint proxy statement and prospectus, must be declared effective by the Securities and Exchange Commission.
- Nasdaq listing: The new Marvell shares must be approved for listing.
- No material adverse effect: Neither company may have suffered a material adverse effect, and each must have performed its obligations in all material respects.
Marvell has said it will file the Form S-4. Once it is filed, it becomes the fullest public account of the deal, including the background to the negotiations and the financial advisers’ analyses, and it is available free on the Securities and Exchange Commission’s EDGAR database.
Where Nvidia Sits in the Deal
Nvidia has a financial interest in both sides. Nvidia announced on 2 March 2026 that it would invest $2 billion in Lumentum, alongside a multibillion-dollar purchase commitment, to support research, future capacity and a new United States fabrication plant. Reuters reports that Nvidia invested $2 billion in Marvell as well in the same period; that second figure has not been confirmed in a filing.
Matt Murphy, Marvell’s chairman and chief executive, addressed the overlap directly, calling the transaction “a double down on supporting Nvidia,” whom he described as the ecosystem leader in the area. On the strategic case, Murphy said that “AI infrastructure is undergoing a fundamental architectural shift toward optical connectivity.” Michael Hurlston, Lumentum’s president and chief executive, said joining Marvell “creates a company uniquely positioned to capitalize on a market opportunity of $550 billion.”
Murphy will remain chairman and chief executive of the combined company. Three Lumentum directors, including Hurlston, will join Marvell’s board, which currently has seven members. Both boards approved the deal unanimously. Optical interconnect has been a focus for Marvell before this deal, and the demand for it is tied closely to the pace of Nvidia’s data-centre system rollouts.
What Is Still Undecided
As of 2 November 2026, the Marvell Lumentum deal is a signed agreement and nothing more. No shareholder vote has been scheduled, the Form S-4 has not been filed, and no competition authority in any jurisdiction has publicly opened a review or set a decision date.
Several things remain unknown. Neither company has identified which approvals it expects to drive the timetable, or named the jurisdictions involved beyond the United States. Neither has said how the more than $1 billion in cost savings breaks down, or over how many years it arrives. The $550 billion addressable market is the companies’ own projection for 2030, not an independently audited figure.
On scale, several outlets described the transaction as the largest technology acquisition on record. Microsoft’s purchase of Activision Blizzard, completed in 2023 at about $69 billion, is generally cited as the largest completed technology deal to date, so a $102.5 billion equity value would exceed it. That comparison only holds if this deal completes, which on its own timetable will not be known until 2028.
Frequently Asked Questions
What Did Marvell Agree to Pay for Lumentum?
Marvell agreed to an all-stock deal with an implied enterprise value of $115 billion including debt, and an equity value of $102.5 billion according to Reuters. Each Lumentum share converts into 4.500 Marvell shares, worth about $1,132 a share when the deal was announced on 2 November 2026.
When Will the Marvell Lumentum Deal Close?
The companies expect to close in the first half of calendar 2028. The merger agreement sets an initial deadline of 1 November 2027, which can be extended to 1 February 2028, 1 May 2028 and finally 1 August 2028 if regulatory approvals have not been obtained.
Is the $1,132 per Share Value Guaranteed?
No. The exchange ratio is fixed at 4.500 Marvell shares and there is no cash, so the dollar value moves with Marvell’s share price until closing. At Marvell’s quoted price of $190.43 on the morning of 2 November 2026, the ratio implied about $857 per Lumentum share.
What Happens if Regulators Block the Deal?
Marvell would owe Lumentum a $3.2 billion regulatory termination fee if the agreement ends because of a final antitrust or foreign-investment restraint, or because the deal was not completed by the outside date, provided the other closing conditions were satisfied or could have been.
Which Approvals Does the Marvell Lumentum Deal Need?
Both companies’ shareholders must vote in favour. The deal also needs expiry of the United States Hart-Scott-Rodino waiting period, certain other regulatory approvals including under foreign investment laws, an effective Form S-4, and Nasdaq approval for the new shares.
Who Will Run the Combined Company?
Matt Murphy stays on as chairman and chief executive. Three Lumentum directors, including chief executive Michael Hurlston, will join Marvell’s seven-member board. Marvell shareholders would own about 67% of the combined company and Lumentum shareholders about 33%.
